18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, Gu P, Ku GY, Chou JF, Capanu M, Antoine A, Loegel D, Feder L, Philemond S, Lyashchenko SK, Lewis JS, Paroder V, Srivastava A, Tang LH, Schoder H, Janjigian YY.
Cytryn SL, et al. Among authors: tang lh.
J Nucl Med. 2024 May 1;65(5):722-727. doi: 10.2967/jnumed.123.267186.
J Nucl Med. 2024.
PMID: 38514081